Transarterial radioembolization (TARE) is a locoregional radiopharmaceutical therapy
based on the delivery of radioactive 90Y microspheres to liver tumors. The importance of …

PET/CT imaging after radioembolization is a viable method for determining the
posttreatment 90Y distribution in the liver. Low true-to-random coincidence ratios in 90Y PET …

Background PET/CT has recently been shown to be a viable alternative to traditional post-
infusion imaging methods providing good quality images of 90 Y-laden microspheres after …

Purpose Evaluation of 90Y liver radioembolization post-treatment clinical data using a whole-
body Biograph Vision Quadra PET/CT to investigate the potential of protocol optimization in …

Purpose The usage of PET/computed tomography (CT) to monitor hepatocellular carcinoma
patients following yttrium-90 (90 Y) radioembolization has increased. Respiratory motion …

Purpose Yttrium‐90 (90Y) microsphere radioembolization enables selective internal
radiotherapy for hepatic malignancies. Currently, there is no standard postdelivery imaging …

Purpose: 90Y‐microspheres are widely used for the radioembolization of metastatic liver
cancer or hepatocellular carcinoma and there is a growing interest for imaging 90Y …

A small positron-generating branch in 90-Yttrium (90 Y) decay enables post-therapy dose
assessment in liver cancer radioembolization treatment. The aim of this study was to validate …

Purpose Transarterial radioembolization (TARE) with yttrium-90 (90 Y) microspheres is a
liver-directed treatment for primary and secondary hepatic malignancies. Personalized …

PET images acquired after liver 90 Y radioembolization therapies are typically very noisy,
which significantly challenges both visualization and quantification of activity distributions …